These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15468007)

  • 1. [Multiple cerebral haemorrhages and antiplatelet drugs].
    Rubí-Callejón J; Arjona A; Serrano-Castro PJ
    Rev Neurol; 2004 Sep 16-30; 39(6):600; author reply 600. PubMed ID: 15468007
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin: real benefits, but real risks, too.
    Harv Heart Lett; 1999 May; 9(9):1-3. PubMed ID: 10200029
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and the risk of hemorrhagic stroke.
    Rosenberg R
    J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
    [No Abstract]   [Full Text] [Related]  

  • 4. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral microbleeds: evidence of heightened risk associated with aspirin use.
    Gorelick PB
    Arch Neurol; 2009 Jun; 66(6):691-3. PubMed ID: 19506128
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorrhagic stroke antithrombotic drugs].
    Alvarez-Sabín J
    Rev Neurol; 2001 May 1-15; 32(9):848-50. PubMed ID: 12803195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic multiple cerebral hemorrhage: are platelet anti-aggregation agents a risk factor?].
    Arjona A; Bartolomé MT; Mata M; Corral F; Blasco MR; Jiménez C
    Rev Neurol; 1997 Dec; 25(148):2069. PubMed ID: 9528077
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin-associated intracerebral hemorrhage in a patient with CADASIL.
    Oh JH; Lee JS; Kang SY; Kang JH; Choi JC
    Clin Neurol Neurosurg; 2008 Apr; 110(4):384-6. PubMed ID: 18207319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile.
    Wammes-van der Heijden EA; Tijssen CC; Egberts AC
    Cephalalgia; 2009 Mar; 29(3):322-30. PubMed ID: 19220314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefits and risks of antiplatelet therapy. A retrospective study].
    Nishimaru K; Yamaguchi T
    Nihon Rinsho; 1992 Feb; 50(2):392-6. PubMed ID: 1613996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study.
    Vernooij MW; Haag MD; van der Lugt A; Hofman A; Krestin GP; Stricker BH; Breteler MM
    Arch Neurol; 2009 Jun; 66(6):714-20. PubMed ID: 19364926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal brain haemorrhage associated with migraine and medication abuse].
    Páez de la Torre E; Lasic-Toccalino G; Mercado-Díez F; Torres-Calloni CM; Balcarce-Bautista PE
    Rev Neurol; 2003 Nov 1-15; 37(9):840-2. PubMed ID: 14606052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
    Toyoda K; Okada Y; Minematsu K; Kamouchi M; Fujimoto S; Ibayashi S; Inoue T
    Neurology; 2005 Oct; 65(7):1000-4. PubMed ID: 16217049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
    Lordkipanidzé M; Diodati JG; Pharand C
    Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin in cardiology--benefits and risks.
    Björklund L; Wallander MA; Johansson S; Lesén E
    Int J Clin Pract; 2009 Mar; 63(3):468-77. PubMed ID: 19222632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best evidence topic report. Aspirin and the risk of intracranial complications following head injury.
    Sakr M; Wilson L
    Emerg Med J; 2005 Dec; 22(12):891-2. PubMed ID: 16299207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans].
    MMW Fortschr Med; 2003 Oct; 145(42):63. PubMed ID: 14655450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.